Autopsy report · NCT01790854

BLeeding Events and Maintenance DoSe of PraSugrel

“Low events rate. Scarce economical resources”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 1 year 11 months before it stopped.
• 195 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

David Antoniucci

Sponsor type

University, hospital or other

Conditions

Adverse Reaction to Antiplatelet Agent; Acute Coronary Syndrome

Interventions

Prasugrel dose 5 mg/day; Prasugrel dose 10 mg/day

Participants

195

Sites

1

Countries

Italy

Trials that died the same way

• Treatment for COVID-19 in High-Risk Adult Outpatients
  “Low number of events contributing to primary outcome” (56% match in meaning)
• Serum Potassium Prediction Using Machine Learning and Single-lead ECG
  “Lack of resources” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.